Clinical Trial Update: Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001) [Phase 1]

View source ↗

Summary

Phase 1 rising-dose study evaluating the safety and pharmacokinetics of EMB-001, a metyrapone/oxazepam combination, in individuals with cocaine use disorder and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder
• Tobacco Use Disorder

Drugs mentioned

• EMB-001 (Metyrapone/Oxazepam combination)

Snippet

Sponsor: Embera NeuroTherapeutics, Inc. | Conditions: Cocaine Use Disorder, Tobacco Use Disorder | Phase 1 | Status: COMPLETED